User profiles for "author:Iuliia Biliavska"

Iuliia Biliavska

ГУ ННЦ "Институт кардиологии им.акад.Н.Д.Стражеско"
Verified email at bigmir.net
Cited by 207

Application of the 2010 ACR/EULAR classification criteria in patients with very early inflammatory arthritis: analysis of sensitivity, specificity and predictive values in the …

I Biliavska, TA Stamm, J Martinez-Avila… - Annals of the …, 2013 - ard.bmj.com
Objective Performance of the 2010 American College of Rheumatology (ACR)/European
League Against Rheumatism (EULAR) rheumatoid arthritis (RA) criteria was analysed in an …

P063 Beyond the clinical trials: real-world retention rate and use of digital interventions in patients with inflammatory arthritis

I Biliavska, E Lenguerrand, J Tobias… - Rheumatology, 2024 - academic.oup.com
Abstract Background/Aims The use of digital tools to deliver healthcare interventions has
increased rapidly. Inadequate engagement and retention are two major barriers to …

P053 Patient engagement in long-term PROMs collection: 48-month observation in real-world clinical practice

I Biliavska, E Lenguerrand, E Sparey, JH Tobias… - …, 2023 - academic.oup.com
Abstract Background/Aims Patient-reported outcome measures (PROMs) allow effective
communication of disease experiences and encourage shared decision-making for people …

Concurrent Oral 9–Rheumatoid Arthritis: Aetiopathogenesis [OP59–OP64] OP59. The Value of Interleukin-17 Serum Level in Rheumatoid Arthritis …

IV Biliavska, OP Bortkevych - Rheumatology, 2010 - academic.oup.com
Abstract Background: Interleukin (IL)-17 is the main Th-1 cytokine, produced by activated T-
lymphocytes. The potential IL-17 value in rheumatoid arthritis (RA) pathogenesis consists of …

[CITATION][C] THE VALUE OF INTERLEUKIN-17 SERUM LEVEL IN RHEUMATOID ARTHRITIS IMMUNOPATHOGENESIS

IV Biliavska, OP Bortkevych - RHEUMATOLOGY, 2010 - OXFORD UNIV PRESS GREAT …